Ding Ding, Ph.D.

Ding Ding, Ph.D. is the founder and chairwoman of Augere Group, which provides corporate finance advisory and investment services focusing on healthcare and climate technology companies globally. Dr. Ding is based in New York and travels to Asia on the regular basis. 

Before starting Augere Group, Dr. Ding spent 21 years in healthcare investment banking and equity research in New York, Hong Kong and China with various leading global banks. She was most recently the head of Asia Healthcare Investment Banking and Capital Markets at Credit Suisse, and the head of China healthcare investment banking at Barclays and Nomura respectively prior to joining Credit Suisse. Dr. Ding and her team advised some of the most important landmark IPOs, private capital raise and M&A transactions across all healthcare subsectors over the past decade, with total transaction value of over $60 billion. Prior to her banking career, Dr. Ding spent 9 years as an equity research analyst, covering US large cap pharma at Lehman Brothers in the #1 Institutional Investor ranked research team in New York, and as the head of China healthcare equity research at UBS in Hong Kong. 

Dr. Ding received her Ph.D. in pharmacology/neuroscience from State University of New York, Downstate Medical Center, and her MBA in finance from the Wharton School, University of Pennsylvania, and BS in electrical engineering from Huazhong University of Science and Technology in China.